09 August 2020 : Clinical Research
Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression
Xiaoxu Fang1B, Dandan Zhang2CD, Wei Zhao3CD, Longfei Gao4DE, Lanping Wang5ABCDEF*DOI: 10.12659/MSM.924670
Med Sci Monit 2020; 26:e924670
Table 4 Relationship between DAAM2 and clinical factors.
Factors | DAAM2 | P* | |
---|---|---|---|
Low | High | ||
Sex | |||
Female | 14 | 23 | 0.047 |
Male | 46 | 34 | |
Age | |||
<50 | 25 | 21 | 0.705 |
≥50 | 35 | 36 | |
Tumor size (cm) | |||
≤5 | 28 | 17 | 0.087 |
>5 | 32 | 40 | |
Tumor number | |||
Single | 55 | 52 | 0.932 |
Multiple | 5 | 5 | |
Histopathological grade | |||
I+II | 44 | 40 | 0.837 |
III | 16 | 17 | |
HBsAg | |||
Negative | 19 | 17 | 0.844 |
Positive | 41 | 40 | |
HCV | |||
Negative | 57 | 50 | 0.197 |
Positive | 3 | 7 | |
Microvascular invasion | |||
Negative | 24 | 30 | 0.392 |
Positive | 33 | 30 | |
Cirrhosis | |||
Negative | 35 | 28 | 0.357 |
Positive | 25 | 29 | |
T stage | |||
I+II | 35 | 22 | 0.032 |
III+IV | 25 | 35 | |
N stage | |||
N0 | 59 | 56 | 0.971 |
N1 | 1 | 1 | |
TNM stage | |||
I+II | 35 | 22 | 0.032 |
III+IV | 25 | 35 | |
DAAM1 | |||
Low | 48 | 47 | 0.815 |
High | 12 | 10 | |
* Calculated by the Chi-square test. HBsAg – hepatitis B surface antien; HCV – hepatitis C virus. |